Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SYNJ IN PLAY
ASFX 0.0048- 0.0049 Looking for a bounce here!
ASFX 0.0072- 0.0073
ONCP 0.0020- 0.0021 WATCH IT HERE!!
ASFX 0.0066- 0.0073 BOUNCE PLAY!
NXHD 0.0001 Nexia's Flagship Salon Reports Record Revenues for Month of May
Wednesday, June 17 2009 8:02 AM, EST Market Wire "US Press Releases "
SALT LAKE CITY, UT -- (MARKET WIRE) -- 06/17/09 -- Nexia Holdings, Inc. (PINKSHEETS: NXHD), a diversified holding company, announced that its flagship salon recorded record revenues for the month of May 2009 . Nexia's CEO Richard Surber stated his belief that, "the increase in revenues at our flagship location for the month of May is an indication of improvements to come in 2009."
Nexia's flagship location reported revenues of $164,194 for the month of May 2009 compared to $149,194 for the comparable period in 2008, an increase of 10%. Mr. Surber added, "So far, our June 2009 gross revenues are looking better than June 2008 ."
Nexia's salon division is gearing up its hiring and marketing efforts to further boost sales in 2009. These efforts coupled with Landis Salons' staff commitment to excellent customer service and the Aveda 12 Points of Difference discussed in this short video at
GRWW 0.0004- 0.0006 WATCH IT!
BIEL will gap up, then a little dip imo!
ASFX ASK just u/t 0.0064- 0.0073 BOUNCE PLAY!
ONCP 0.0018- 0.0024 Watch it!
ASFX 0.0064 - 0.0065 Bounce play for tomorrow :)
ASFX going back GREEN
ASFX 0.0077- 0.0078 Posted by: WiseTrader Date: Tuesday, June 16, 2009 2:14:22 PM
In reply to: None Post # of 1507098
ASFX bouncing here 0.0056-0.0057 !!
ASFX 0.0070- 0.0072 What a bounce :)
ASFX 0.0069 - 0.0070 FAST
ASFX 0.0064 - 0.0065
ASFX GOING BACK UP :)
ASFX 0.0062 - 0.0063 now
ASFX BOUNCE PLAY NOW
ASFX bouncing here 0.0056-0.0057 !!
IN ASFX for a bounce!
BIEL might dip a little here
BIEL ALERT first to be posted here :)
http://investorshub.advfn.com/boards/read_msg.aspx?Message_id=38718585&txt2find=biel
IF you like this ALERT Click here :)
http://investorshub.advfn.com/boards/addPersonMrk.asp?user=121377
Sold all @ ask :)
Thanks :)
BIEL 0.0120 - 0.0125
BIEL Nice gain,Profit is NICER JMHO
BIEL in @ 0.0070 almost a double 4 me :)
BIEL 0.0107 - 0.0110
ONCP 0.0020 -0.0024 Let's go !
ONCP 0.0019 - 0.0020 bid support now
BIEL ..I was right >>Posted by: WiseTrader Date: Monday, June 15, 2009 2:24:59 PM
In reply to: None Post # of 1506906
BIEL 0.0070 -0.0072 watch it going over 0.01 !!filed for FDA Clearance today
Monday, June 15 2009 11:00 AM, EST BioElectronics Is Filing for 510(k) Clearance With FDA for Its Allay(TM) Product Market Wire "US Press Releases "
FREDERICK, MD -- (MARKET WIRE) -- 06/15/09 -- BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced it is filing an application with the U.S. Food and Drug Administration ( FDA ) for 510(k) clearance to market its Allay(TM) Menstrual Pain Relief Patch product. The filing follows a very successful double blinded, placebo controlled clinical trial in which 71% of women in the active group reported either complete elimination or a reduction in their typical menstrual pain symptoms, with 49% showing at least a 50% reduction in pain associated with dysmenorrhea.
"While between 60% and 70% of women suffer from pain during menstruation, with millions of women experiencing pain severe enough to significantly restrict daily activities, there are very few safe alternatives for pain relief," commented Andrew Whelan , CEO of BioElectronics, Corp. "The most widely used treatment for dysmenorrheal is acetaminophen, but it is also the leading causes of liver failure in the U.S(1). The Allay Menstrual Pain Relief Patch offers a far safer, highly effective and drug-free solution for millions of women who suffer from period pain and cramps. We are excited to bring this product to market."
The Allay Menstrual Pain Relief Patch is based on Pulsed Electromagnetic Field (PEMF) therapy, which is proven safe and effective in hundreds of peer reviewed clinical studies. Using advance semiconductor and micro-battery technologies, BioElectronics has achieved a technological breakthrough in shrinking PEMF technology into a very small form factor that has been packaged into a wafer thin patch that can be worn directly on the skin. The product is currently available over the counter in most counties outside of the United States . The filing with the FDA , is designed to make this drug-free pain relieving technology widely available to women within the United States .
About BioElectronics Corporation
BioElectronics Corporation is the maker of ActiPatch® Therapy, RecoveryRx(TM) Devices, HealFast(TM) Therapy (http://www.healfasttherapy.com) and the Allay(TM) family of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see http://www.BioElectronicsCorp.com.
(1) Source reference: Larson AM et al, Acetaminophen-Induced Acute Liver Failure: Results a United States Multicenter, Prospective Study. HEPATOLOGY 2005;42:1364-1372
Tylenol is a registered Trademark of McNEIL-PPC, Inc.
Contact: For media enquiries, please contact: Joe Noel BioElectronics Corp. (925) 922-2560
HRNF(shakerzzz!!!)
BIEL 0.0095 - 0.0098
ONCP 0.0020 - 0.0021 UP 300%
Posted by: WiseTrader Date: Monday, June 15, 2009 11:05:41 AM
In reply to: None Post # of 1506834
BIEL FDA NEWS:
Monday, June 15 2009 11:00 AM, EST BioElectronics Is Filing for 510(k) Clearance With FDA for Its Allay(TM) Product Market Wire "US Press Releases "
FREDERICK, MD -- (MARKET WIRE) -- 06/15/09 -- BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced it is filing an application with the U.S. Food and Drug Administration ( FDA ) for 510(k) clearance to market its Allay(TM) Menstrual Pain Relief Patch product. The filing follows a very successful double blinded, placebo controlled clinical trial in which 71% of women in the active group reported either complete elimination or a reduction in their typical menstrual pain symptoms, with 49% showing at least a 50% reduction in pain associated with dysmenorrhea.
"While between 60% and 70% of women suffer from pain during menstruation, with millions of women experiencing pain severe enough to significantly restrict daily activities, there are very few safe alternatives for pain relief," commented Andrew Whelan , CEO of BioElectronics, Corp. "The most widely used treatment for dysmenorrheal is acetaminophen, but it is also the leading causes of liver failure in the U.S(1). The Allay Menstrual Pain Relief Patch offers a far safer, highly effective and drug-free solution for millions of women who suffer from period pain and cramps. We are excited to bring this product to market."
The Allay Menstrual Pain Relief Patch is based on Pulsed Electromagnetic Field (PEMF) therapy, which is proven safe and effective in hundreds of peer reviewed clinical studies. Using advance semiconductor and micro-battery technologies, BioElectronics has achieved a technological breakthrough in shrinking PEMF technology into a very small form factor that has been packaged into a wafer thin patch that can be worn directly on the skin. The product is currently available over the counter in most counties outside of the United States . The filing with the FDA , is designed to make this drug-free pain relieving technology widely available to women within the United States .
About BioElectronics Corporation
BioElectronics Corporation is the maker of ActiPatch® Therapy, RecoveryRx(TM) Devices, HealFast(TM) Therapy (http://www.healfasttherapy.com) and the Allay(TM) family of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see http://www.BioElectronicsCorp.com.
(1) Source reference: Larson AM et al, Acetaminophen-Induced Acute Liver Failure: Results a United States Multicenter, Prospective Study. HEPATOLOGY 2005;42:1364-1372
Tylenol is a registered Trademark of McNEIL-PPC, Inc.
Contact: For media enquiries, please contact: Joe Noel BioElectronics Corp. (925) 922-2560
BIEL 0.0091 - 0.0094
ONPC 0.0018- 0.0019 might rebound again!
ONCP 0.0029 - 0.0030
ONCP 0.0023- 0.0024